Resource Centre
)
)
)
)
Quantification of residual plasmid DNA and SV40 promoter-enhancer sequences in Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario
- Biopharma
- Plasmid
- mRNA
- Flongle
September 6 2025
)
Workflow overview: pharmacogenomics with adaptive sampling
- Biopharma
- Pharmacogenomics
- Human genomics
- Clinical research
- Targeted
- Variant calling
August 5 2025
Case study: streamlining routine CRISPR validation with Oxford Nanopore sequencing
- Biopharma
- Amplicons
- Targeted
- GridION
- DNA
July 30 2025
)
)
)
Long read sequencing reveals transgene concatemerisation and vector sequences integration following AAV-driven electroporation of CRISPR RNP complexes
- Biopharma
- Animal
- AAV
- Cas enrichment
- Adaptive sampling
- MinION
June 4 2025
)
EPI2ME end-to-end workflows for biopharma quality control of plasmids and mRNA
- Biopharma
- EPI2ME
- London Calling
May 20 2025
)
Stepping into the future of nanopore protein sequencing
- Biopharma
- MinION
- GridION
- Multiomics
- Cancer research
- Clinical research
May 19 2025
)
Nanopore sequencing reveals psilocybin-induced brain 5mC/5hmC epigenetic changes
- Biopharma
- PromethION 2
- Epigenetics
- Gene expression
- Multiomics
- Animal
May 19 2025
)
Masterclass: How to sequence full-length plasmids in your own lab | LC25
- Biopharma
- Microbiology
- Bioinformatics
- Infectious disease
- MinION
- GridION
May 19 2025
)
Flyer: pharmacogenomics with Twist
- Biopharma
- Pharmacogenomics
- Human genomics
- Clinical research
- Targeted
- Variant calling
May 6 2025
)
A sensitive sample preparation pipeline for adventitious virus detection using Oxford Nanopore sequencing
- Biopharma
- Virus
- GridION
April 24 2025
)
Evaluation of the loading capacity and patterns of packaged DNA in AAV genomes of different sizes using long-read sequencing
- Biopharma
- AAV
- MinION
April 19 2025
)
Introductory guide: unlocking the biopharma development pipeline with Oxford Nanopore
- Biopharma
- Direct analysis
- Amplicons
- Plasmid
- mRNA
- AAV
April 16 2025
)
Re-adenylation by TENT5A enhances efficacy of SARS-CoV-2 mRNA vaccines
- Biopharma
- mRNA
- Virus
- Infectious disease
April 16 2025
)
Workflow overview: whole-plasmid sequencing
- Biopharma
- Microbiology
- Infectious disease
- Plasmid
- Bacteria
- DNA
April 10 2025
Navigating cell and gene therapy: the benefits of whole-genome profiling
- Biopharma
- AAV
- Plasmid
- Webinar
March 25 2025
